![Paolo Pucci](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paolo Pucci
Directeur/Membre du Conseil chez
WEST PHARMACEUTICAL SERVICES, INC.
Fortune : 4 M $ au 31/05/2026
Profil
Mr. Paolo Pucci is an Independent Director at Tarus Therapeutics, Inc., an Independent Director at Replimune Group, Inc. and a Lead Independent Director at West Pharmaceutical Services, Inc. He is on the Board of Directors at Tarus Therapeutics, Inc., Replimune Group, Inc. and West Pharmaceutical Services, Inc. Mr. Pucci was previously employed as a Lead Independent Director by Trillium Therapeutics, Inc., an Independent Non-Executive Director by Merus NV, an Independent Director by NewLink Genetics Corp., a Non-Executive Director by Algeta ASA, an Independent Director by Dyax Corp., a Chief Executive Officer by ArQule, Inc., a President-Oncology & Global Specialty Medicines by Bayer AG, a Senior Vice President by Bayer Pharma AG, a President-US Pharmaceutical Operations by Bayer Pharmaceuticals Corp., and a Managing Director by Eli Lilly Sweden AB. He received his undergraduate degree from Università degli Studi di Napoli Federico II and an MBA from The University of Chicago Booth School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 04/05/2026 | 10 947 ( 0,02 % ) | 4 M $ | 31/05/2026 | |
| 01/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Paolo Pucci
| Sociétés | Poste | Début |
|---|---|---|
| WEST PHARMACEUTICAL SERVICES, INC. | Directeur/Membre du Conseil | 12/09/2016 |
| REPLIMUNE GROUP, INC. | Directeur/Membre du Conseil | 01/04/2020 |
Tarus Therapeutics, Inc.
 Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on nucleotide metabolism in cancer | Directeur/Membre du Conseil | 02/12/2020 |
Anciens postes connus de Paolo Pucci
| Sociétés | Poste | Fin |
|---|---|---|
| MERUS N.V. | Directeur/Membre du Conseil | 12/12/2025 |
| TRILLIUM THERAPEUTICS | Directeur/Membre du Conseil | 17/11/2021 |
| LUMOS PHARMA, INC. | Directeur/Membre du Conseil | 31/10/2018 |
| DYAX CORP. | Directeur/Membre du Conseil | 22/01/2016 |
| ALGETA ASA | Directeur/Membre du Conseil | 01/03/2014 |
Formation de Paolo Pucci
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
46
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that researches and develops therapeutics to treat cancers & rare diseases | Health Technology |
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Bayer AG
 Bayer AG Pharmaceuticals: MajorHealth Technology Provides health care, nutrition and high-tech material services | Health Technology |
West Pharmaceutical Services, Inc.
 West Pharmaceutical Services, Inc. Medical SpecialtiesHealth Technology Manufactures and markets pharmaceuticals, biologics, vaccines & consumer healthcare products | Health Technology |
NewLink Genetics Corp.
 NewLink Genetics Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops, and commercializes novel immunotherapeutic products for treatment of cancer | Health Technology |
Bayer Pharmaceuticals Corp. | |
Trillium Therapeutics, Inc.
 Trillium Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops and manufactures medicines & therapies for cancer | Health Technology |
Bayer Pharma AG
 Bayer Pharma AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Engages in the development of products for the treatment of cancer | Health Technology |
Merus NV
 Merus NV BiotechnologyHealth Technology Discovers and develops therapeutics for cancer treatment | Health Technology |
Eli Lilly Sweden AB
 Eli Lilly Sweden AB Eli Lilly Sweden AB is a pharmaceutical company that develops and delivers medicines for conditions including obesity, diabetes, cancer, immunology, pain, neurological disorders, osteoporosis, cardiovascular diseases, and endocrinology. The company is based in Solna, Sweden. The Swedish company also provides educational resources for healthcare professionals, such as live online lectures on obesity and type 2 diabetes, and offers information on medicines, patient safety, and company news through its website. The company was founded by Colonel Eli Lilly. | |
Università degli Studi di Napoli Federico II
 Università degli Studi di Napoli Federico II Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Chicago Booth School of Business
 The University of Chicago Booth School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Replimune Group, Inc.
 Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on nucleotide metabolism in cancer | Health Technology |
Choisissez Zonebourse 
